Literature DB >> 18378435

Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women--a cross-racial validation.

Juey-Jen Hwang1, Hung-Yuan Li, Gow-Jen Shieh, Yu-Fen Chien, Cyue-Huei Hua, Jou-Wei Lin.   

Abstract

BACKGROUND AND AIMS: This study was designed to elucidate the role of C-reactive protein (CRP) as an inflammatory marker in the development of the metabolic syndrome (MS). METHODS AND
RESULTS: A total of 333 women without current medication attended an obesity-screening programme held in Yun-Lin, Taiwan. Anthropometric measurements were obtained; biochemical profiles, lipid profiles and high-sensitivity CRP (hsCRP) were measured. A structural equation model (SEM) was constructed to demonstrate that obesity might initiate the sequential pathway that leads to a pro-inflammatory state and other metabolic derangements. The results of SEM in the Taiwanese women showed that obesity was positively associated with elevated CRP (B=0.69, p<0.001). The pro-inflammatory state could result in insulin resistance (B=0.57, p<0.001), which in turn could lead to dyslipidaemia (B=0.46, p<0.01). The association between obesity and hypertension was positive and direct (B=0.43, p<0.01) without the intermediation of inflammation or insulin resistance. The implications could be reproduced when the same model was applied to the metabolic profiles of the Caucasian participants in the National Health and Nutrition Examination Survey 1999-2002.
CONCLUSION: Our study has demonstrated that obesity plays the central role in leading to hypertension and a pro-inflammatory state, insulin resistance and dyslipidaemia. The SEM has provided a comprehensive view to illustrate the complex interplay of the main components in the development of the MS, and this approach can be generalized to different populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378435     DOI: 10.1016/j.numecd.2007.11.006

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  The role of serum C-reactive protein in women with lower urinary tract symptoms.

Authors:  Sheng-Mou Hsiao; Ho-Hsiung Lin; Hann-Chorng Kuo
Journal:  Int Urogynecol J       Date:  2012-03-16       Impact factor: 2.894

2.  The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study.

Authors:  Mizue Fujii; Hirofumi Ohnishi; Shigeyuki Saitoh; Hiroshi Akasaka; Tetsuji Miura; Mitsuru Mori
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

4.  Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.

Authors:  Chih-Neng Hsu; Chia-Hsuin Chang; Yu-Sheng Lin; Jou-Wei Lin; James L Caffrey
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

5.  The interplay between inflammation, physical activity and metabolic syndrome in a remote male geriatric community in Southern Taiwan: the Tianliao Old People (TOP) study 03.

Authors:  Chia-Ling Chang; Po-Tseng Lee; Wei-Ting Chang; Chin-Sung Chang; Jyh-Hong Chen; Liang-Miin Tsai; Chih-Hsing Wu; Ping-Yen Liu
Journal:  Diabetol Metab Syndr       Date:  2013-10-14       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.